Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
EMvision Medical Devices Ltd. ( (AU:EMV) ) has provided an announcement.
EMVision Medical Devices Ltd has appointed Mr. Karl Pechmann as the new Chief Financial Officer, effective February 2026. Mr. Pechmann’s extensive experience in capital management and organizational development in the medical technology sector aligns with EMVision’s strategic shift from research and development to commercialization, aiming to build sustainable value for stakeholders.
The most recent analyst rating on (AU:EMV) stock is a Hold with a A$2.00 price target. To see the full list of analyst forecasts on EMvision Medical Devices Ltd. stock, see the AU:EMV Stock Forecast page.
More about EMvision Medical Devices Ltd.
EMVision Medical Devices Limited is an Australian medical device company focused on developing innovative, portable, non-invasive, and affordable neurodiagnostic devices. The company’s vision is to enhance the timely diagnosis and treatment of stroke and other critical medical emergencies at the point-of-care.
Average Trading Volume: 85,593
Technical Sentiment Signal: Sell
Current Market Cap: A$171.9M
See more insights into EMV stock on TipRanks’ Stock Analysis page.